Noida, India

Jwalant A Shastri

This inventor holds 1 USPTO granted patent. Top assignee: Jubilant Organosys Limited. Active years: 2011.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jwalant A Shastri: Innovator in Pharmaceutical Chemistry

Introduction

Jwalant A Shastri is a notable inventor based in Noida, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel processes for drug synthesis. His work is characterized by a focus on producing pure and effective pharmaceutical compounds.

Latest Patents

Jwalant A Shastri holds a patent for a process titled "Process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine." This innovative process involves the reaction of 2-(2-aminoanilino)-5-methylthiophene-3-carbonitrile with N-methyl piperazine, along with N-methylpiperazine acid salt, to yield the desired compound. Additionally, he has disclosed a method for obtaining Polymorphic Form I of the compound by crystallizing the crude product in a mixture of solvents. Jwalant A Shastri has 1 patent to his name.

Career Highlights

Jwalant A Shastri is currently employed at Jubilant Organosys Limited, a prominent player in the pharmaceutical industry. His role involves research and development, where he applies his expertise to enhance drug formulations and processes. His contributions have been instrumental in advancing the company's innovative capabilities.

Collaborations

Throughout his career, Jwalant has collaborated with talented professionals, including Akshat Bhatnagar and Rajesh Kumar Thaper. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in pharmaceutical chemistry.

Conclusion

Jwalant A Shastri exemplifies the spirit of innovation in the pharmaceutical industry. His dedication to developing efficient processes for drug synthesis has made a significant impact on the field. His work continues to inspire future advancements in pharmaceutical research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…